论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
在中国,从下呼吸道样本中检测出惠普尔养障体患者的临床特征
Authors Chen Q , Gao B, Guo W , Liu H, Guo J
Received 7 May 2025
Accepted for publication 7 July 2025
Published 9 July 2025 Volume 2025:18 Pages 3439—3448
DOI https://doi.org/10.2147/IDR.S530624
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Professor Chi H. Lee
Qi Chen,1 Bo Gao,2 Wei Guo,1 Hao Liu,3 Jun Guo1,2
1Department of Geriatrics, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing, 102218, People’s Republic of China; 2Department of Respiratory and Critical Care Medicine, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing, 102218, People’s Republic of China; 3Department of Pathology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing, 102218, People’s Republic of China
Correspondence: Jun Guo, Department of Geriatrics, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, 168 Litang Road, Changping District, Beijing, People’s Republic of China, Tel +8613681573493, Email junguo_med@tsinghua.edu.cn
Introduction: Tropheryma whipplei (TW) can cause various infections that are relatively rare worldwide. With the development of molecular biology, the ability to detect TW has increased in recent years. However, its significance in lower respiratory tract samples remains unclear.
Patients and Methods: We collected the clinical data of 5 patients admitted to a tertiary care hospital in Beijing with TW detected by bronchoalveolar lavage fluid (BALF) mNGS and reviewed all case reports of TW-related pneumonia in China (up to November 2024) to analyse the features of this disease among Chinese patients.
Results: A total of 41 articles reporting 55 cases were identified. Fifty-two (94.5%) patients had respiratory symptoms. Fifteen (27.3%) patients developed severe pneumonia. Confirmation of TW infection was achieved through methods including the assessment of TW reads and relative abundance (63.6%), empirical treatment (18.2%), lung biopsy histopathology (14.5%), and qPCR confirmation (3.6%). Fifty (90.9%) patients received antibiotic therapy. Fifty-one (92.7%) patients had a good prognosis.
Conclusion: TW can enter the lower respiratory tract through multiple routes. When TW sequences are detected in lower respiratory tract samples, it is important to consider not only the read and relative abundance but also histopathological findings such as interstitial pneumonia and the presence of PAS- or PASM-positive bacilli within foamy macrophages as they can aid in diagnosing TW infection. MDT discussions and empirical antibiotic therapy targeting TW are viable options when a patient’s condition deteriorates. Microbiological testing of saliva, gastric fluid, blood, and faeces may help clarify the source of TW.
Keywords: Tropheryma whipplei, lower respiratory tract, metagenomic next-generation sequencing, bronchoalveolar lavage fluid, pneumonia